Home News & Articles Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults 29/09/2020 A Phase 1 clinical trial enrolled 40 healthy volunteers. Read More
